TBIO stock icon

Telesis Bio
TBIO

$3.89
0.51%

Market Cap: 6.55M

 

About: Telesis Bio Inc is a synthetic biology company focused on enabling researchers to rapidly, accurately, and reproducibly build or write high-quality synthetic DNA and mRNA that is ready to use in many downstream synthetic biology-enabled markets. It manufactures and sells laboratory equipment, specifically synthetic biology instruments, reagents, and associated products and related services. Its products comprise of BioXp system, BioXp kits, Benchtop reagents and BioXp biofoundry services.

Employees: 138

0
Funds holding %
of 6,702 funds
Analysts bullish %
News positive %

Fund manager confidence

Based on 2024 Q1 SEC filings by fund managers ($100M+ AUM)

6% more capital invested

Capital invested by funds: $4.5M [Q4 2023] → $4.77M (+$267K) [Q1 2024]

0% more funds holding in top 10

Funds holding in top 10: 1 [Q4 2023] → 1 (+0) [Q1 2024]

0% more repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 5

1.49% less ownership

Funds ownership: 37.63% [Q4 2023] → 36.14% (-1.49%) [Q1 2024]

19% less funds holding

Funds holding: 26 [Q4 2023] → 21 (-5) [Q1 2024]

83% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 6

Research analyst outlook

We haven’t received any recent analyst ratings for TBIO.

Financial journalist opinion